menu
    • menu

    Company profile for Chirogate International

    Chirogate-PSE
    News
    BMS Expands AI Integration System-Wide with Anthropic Claude

    21 May 2026

    // FIERCE PHARMA

    Incyte, Genesis Expand Molecular AI For Drug Discovery

    21 May 2026

    // BUSINESSWIRE

    Dr Reddy's launches oral semaglutide biosimilar Obeda in India

    21 May 2026

    // ECONOMICTIMES

    DATA COMPILATION
    #PharmaFlow

    Chirogate VB RM

    Contact Supplier

    Website

    CPhI China

    Booth #E1D22b

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cep-q1-2026-update-cep-2-0-edqm-s-new-guidelines-strengthen-ecosystem-indian-firms-top-list-of-ceps-issued

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Chirogate is a professional Prostaglandin manufacturer.

    Related CompaniesRelated Companies

    About

    Chirogate, established in 1999, is a leading supplier of niche-market molecules, specializing in prostaglandins. Focused on quality and compliance, it offers competitively priced prostaglandin APIs to regulated and unregulated markets worldwide. Using proprietary processes and advanced technology, Chirogate adheres to cGMP and international manufacturing standards, ensuring product safety and quality. The company has passed successful regulatory inspections, including by the USFDA. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Chirogate InternationalTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    No.2, Shih 4th Rd., Youth Industrial Park, Yangmei Dist., Taoyuan City
    Telephone
    Telephone
    +886 34963808
    Client Email
    Email
    sales@chirogate.com
    Client Website
    Website
    https://www.chirogate.com/about.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/soundfo/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI China

    Booth #E1D22b

    envelop Contact Supplier

    CPhI China

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2026

    read-more

      https://www.pharmacompass.com/pdf/party/content/chirogate-international-party-content-28163.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/chirogate-international-party-content-1656581675.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Prostaglandin market to cross US$ 1.27 bn by 2035; Liquidia’s Yutrepia okayed for pulmonary hypertension

    Prostaglandin market to cross US$ 1.27 bn by 2035; Liquidia’s Yutrepia okayed for pulmonary hypertension

    Prostaglandins are natural fatty acid compounds produced by the human body. They are made from a type of fat known as arachidonic acid and act like messengers, controlling many functions such as inflammation, blood flow, muscle contraction, and fluid drainage in the eye. Prostaglandin APIs are synthetic (lab-made) versions of natural prostaglandins that are used to create medicines. Prostaglandin-based medicines are used in obstetrics and gynecology, gastroenterology, urology, and cosmetics, and their use is also being explored in certain cardiovascular and respiratory conditions. One of the largest and most important uses of prostaglandin APIs is in ophthalmology (eye care), where they are used as first-line therapy for open-angle glaucoma (a chronic, progressive eye disease) and ocular hypertension (a condition where pressure inside the eye is consistently higher than normal). In ophthalmic applications, these drugs usually serve as prodrugs – inactive in the formulation but converted into their active form after entering the eye.According to estimates, the global prostaglandin market is valued at US$ 0.63 billion in 2025 and is poised to grow from US$ 0.68 billion in 2026 to US$ 1.27 billion by 2035, growing at a CAGR of 7.1 percent between 2026 and 2035.Prostaglandin API manufacturing is a highly specialised field, with only a few experienced manufacturers. Companies such as EUROAPI, Cayman Pharma, Chirogate International, Kyowa Pharma Chemical, Everlight Chemical, and Yonsung Fine Chemicals are key players with strong capabilities in complex chemistry.FDA allows Glaukos’ iDose TR to be re-administered for treating eye diseases; approves Liquidia’s Yutrepia The prostaglandin market continues to see steady regulatory activity and innovations. In ophthalmology, Glaukos Corporation’s iDose TR received a labelling supplement from the US Food and Drug Administration (FDA) that allows for re-administration of the medication indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). The intracameral implant was originally approved in December 2023 for single use. This update was supported by long-term safety data demonstrating good tolerability in patients with OAG and OHT. Similarly, Santen Pharmaceutical secured manufacturing and marketing approval in Japan for Setaneo (sepetaprost) ophthalmic solution 0.002% in August 2025 for the treatment of glaucoma and OHT. In April 2025, Santen also received approval in China for Tapcom (tafluprost + timolol maleate), a preservative-free fixed-dose combination therapy that lowers intraocular pressure (IOP) in patients with OAG and OHT.Beyond ophthalmology, prostaglandin APIs are also driving advancements in respiratory care. Liquidia Corporation received FDA approval in May 2025 for Yutrepia (treprostinil) inhalation powder for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). While PAH is a serious and progressive disease where blood pressure in the lung arteries rises, causing them to narrow and harden, PH-ILD is a serious complication in which high blood pressure develops in the lung arteries due to lung scarring. Yutrepia is the first and only prostacyclin dry-powder formulation enabled by Liquidia’s proprietary technology.  Access the Interactive Dashboard on Prostaglandin Developments (Free Excel Available)Nicox’s drug scores phase 3 win in glaucoma, OHT; United seeks expanded approval for Tyvaso to treat pulmonary fibrosisInnovation in prostaglandins is increasingly focused on enhanced efficacy and sustained drug delivery. French ophthalmology company Nicox has reported positive phase 3 results for its ophthalmic solution NCX 470, demonstrating consistent lowering of intraocular pressure in OAG and OHT. Nicox is likely to submit a new drug application for NCX 470 sometime soon, with a potential approval and launch expected in 2027.Meanwhile, US-based SpyGlass Pharma is advancing sustained-release innovation through intraocular lens (IOL)-based and ring-based drug delivery systems. Its Bimatoprost Drug Pad–Intraocular Lens (BIM-IOL) system (currently in phase 3 trials) integrates drug delivery with cataract surgery to enable sustained therapy for up to three years. The company is also developing a preclinical Bimatoprost Drug Ring System (BIM-DRS) designed for similarly extended drug release. In respiratory indications, Insmedis progressing treprostinil palmitil inhalation powder through phase 3 trials for PH-ILD, as well as for idiopathic pulmonary fibrosis and PAH.Additionally, United Therapeutics is expanding the clinical scope of Tyvaso DPI (treprostinil). Following its global approval in 2022 for PAH, the therapy is now under regulatory review in the US and Canada for progressive pulmonary fibrosis and idiopathic pulmonary fibrosis.  Access the Interactive Dashboard on Prostaglandin Developments (Free Excel Available)Glaukos sets up new R&D facility in Alabama, Inke acquires Pharmanoid to strengthen presence in prostaglandins Several players are expanding capacities due to rising demand across ophthalmology. Glaukos Corporation is setting up a new research, development, and manufacturing facility in Huntsville, Alabama. The planned 200,000 square-foot site, to be built on a 25-acre campus in Cummings Research Park, envisages an investment of over US$ 80 million. Expected to be completed by 2030, the facility is designed to augment the company’s existing infrastructure and support long-term growth, particularly in ophthalmic therapies including sustained-release drug delivery systems.EUROAPIis undertaking a significant capacity expansion at its Budapest site. The company has committed €50 million (US$ 54.8 million) to install a new state-of-the-art production plant focused on prostaglandins. The project aims to debottleneck existing operations and introduce new multi-purpose manufacturing equipment, ultimately more than doubling the site’s prostaglandin production capacity by 2027. The expansion will also strengthen EUROAPI’s highly potent API (HPAPI) capabilities.Alongside capacity additions by established players, the market is also witnessing consolidation and capability expansion through acquisitions. For instance, Essential Pharma acquired Ventavis (iloprost trometamol) from Bayer AG, including rights to the accompanying Breelib nebuliser delivery technology. Ventavis, a prostacyclin analogue, is a well-established treatment for adult patients with primary pulmonary hypertension.Inke strengthened its presence in ophthalmology-focused high-potency APIs (HPAPIs), including prostaglandins, through the acquisition of Pharmanoid in December 2025. Backed by regulatory approvals across 25+ countries, Pharmanoid enhances Inke’s capabilities in complex API production and supports its ambition to build a leading European platform for advanced API development and manufacturing. The Barcelona facility is capable of producing and handling APIs across all potency levels while adhering to SafeBridge Scale OEB4 (Occupational Exposure Band 4) containment protocols, a classification for high-potency substances requiring strict controls to limit occupational exposure.With more than two decades of experience, Inke is recognized for innovating and manufacturing high-quality APIs, delivering expertise, safety, and excellence across inhalation, CNS, and ophthalmic therapies, while supporting pharmaceutical companies worldwide. The ophthalmic API commercial portfolio includes bimatoprost, latanoprost, tafluprost, and travoprost, while the next-generation prostaglandin analog pipeline includes bimatoprost grenod and latanoprostene bunod.  Access the Interactive Dashboard on Prostaglandin Developments (Free Excel Available)Our viewInnovation is guiding the prostaglandins market towards long-acting, sustained-release formulations and novel delivery systems. These innovations are driving steady growth in prostaglandins, while capacity expansions are strengthening capabilities in complex and highly potent APIs. Overall, this remains a niche but important market to watch. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 745

    https://www.pharmacompass.com/radio-compass-blog/prostaglandin-market-to-cross-us-1-27-bn-by-2035-liquidia-s-yutrepia-okayed-for-pulmonary-hypertension

    #PharmaFlow by PHARMACOMPASS
    14 May 2026
    Share Share

    USDMF

    read-more
    read-more

    01

    Bimatoprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21382

    Submission : 2008-02-26

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Carboprost Tromethamine

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : Complete

    Rev. Date : 2020-12-01

    Pay. Date : 2020-09-17

    DMF Number : 33807

    Submission : 2019-07-09

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Dinoprostone

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37975

    Submission : 2023-04-26

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Hexadecyl Treprostinil

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29207

    Submission : 2015-08-12

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Iloprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 41186

    Submission : 2025-02-04

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Isomer Free Latanoprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-04-13

    Pay. Date : 2017-02-21

    DMF Number : 31372

    Submission : 2017-03-14

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Latanoprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 18343

    Submission : 2005-05-24

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Latanoprostene Bunod

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 37976

    Submission : 2023-04-24

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Tafluprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : Complete

    Rev. Date : 2025-04-02

    Pay. Date : 2025-02-14

    DMF Number : 33632

    Submission : 2019-04-11

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Travoprost

    Taiwan
    arrow
    CPhI China
    Booth #E1D22b
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothChirogate is a professional Prostaglandin manufacturer.

    Chirogate International

    GDUFA

    DMF Review : Complete

    Rev. Date : 2012-11-23

    Pay. Date : 2012-12-17

    DMF Number : 22738

    Submission : 2009-04-20

    Status : Active

    Type : II

    Chirogate CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KEY PRODUCTS

    read-more
    read-more

    TOP RANKED SUPPLIER FOR:

    Sponsored Ads.
    full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view
    Sponsored Ads.full-view

    Inspections and registrations

    Check the inspections & registration from this company
    Chirogate Popup

    ABOUT THIS PAGE

    Contact Chirogate International and get a quotation

    Chirogate International is a supplier offers 23 products (APIs, Excipients or Intermediates).

    Find Latanoprost bulk with DMF, CEP, JDMF offered by Chirogate International

    Find Carboprost Tromethamine bulk with DMF, CEP offered by Chirogate International

    Find Latanoprost bulk with DMF, JDMF offered by Chirogate International

    Find Tafluprost bulk with DMF, JDMF offered by Chirogate International

    Find Bimatoprost bulk with DMF offered by Chirogate International

    Find Dinoprostone bulk with DMF offered by Chirogate International

    Find Iloprost bulk with DMF offered by Chirogate International

    Find Isopropyl Unoprostone bulk with DMF offered by Chirogate International

    Find Latanoprostene Bunod bulk with DMF offered by Chirogate International

    Find Travoprost bulk with DMF offered by Chirogate International

    Find Treprostinil Sodium bulk with DMF offered by Chirogate International

    Find Alprostadil bulk offered by Chirogate International

    Find Alprostadil Alfadex bulk offered by Chirogate International

    Find Beraprost Sodium bulk offered by Chirogate International

    Find Cloprostenol Sodium bulk offered by Chirogate International

    Find Dinoprost bulk offered by Chirogate International

    Find Dinoprost Tromethamine bulk offered by Chirogate International

    Find Epoprostenol Sodium bulk offered by Chirogate International

    Find Limaprost Alfadex bulk offered by Chirogate International

    Find Lubiprostone bulk offered by Chirogate International

    Find Misoprostol bulk offered by Chirogate International

    Find Treprostinil Diolamine bulk offered by Chirogate International

    Find Treprostinil Palmitil bulk offered by Chirogate International

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search